NYC CONNECT: NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation

Sponsor
NYU Langone Health (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05742178
Collaborator
Centers for Disease Control and Prevention (U.S. Fed)
2,160
1
2
42
51.4

Study Details

Study Description

Brief Summary

NYC CONNECT will carry out a randomized controlled trial (RCT) which will assess the relative effectiveness of two evidence-based strategies to increase cancer screening rates for breast, cervical, and colorectal cancer. The RCT will compare the effectiveness of using a combination of 1) culturally and linguistically tailored cancer education materials and 2) community health workers (CHWs) to provide navigation services for cancer screening (the "patient navigation" [PN] arm) versus providing culturally and linguistically tailored cancer education only (the "less intensive" [LI] arm). The study population will include individuals who are due for breast, cervical, or colorectal cancer screening. All individuals recruited to the study will be provided navigation for unmet social determinants of health (SDH) needs.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Patient Navigation (PN) - More Intensive
  • Behavioral: Educational Materials
  • Behavioral: Patient Navigation (PN) - Less Intensive
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
2160 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation Randomized Controlled Trial (NYC CONNECT)
Anticipated Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Oct 1, 2026
Anticipated Study Completion Date :
Oct 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Patient Navigation (PN)

Participants randomized to the PN arm will receive community health worker (CHW)-administered PN for cancer screening + social service needs + culturally and linguistically tailored cancer education. All individuals will complete a survey at baseline, 3 months, and 6 months.

Behavioral: Patient Navigation (PN) - More Intensive
The PN intervention will be administered by trained, bilingual CHWs: they will screen participants for cancer screening status and social needs and provide navigational support to cancer screening and social services.

Behavioral: Educational Materials
Both PN and LI participants will receive tailored educational materials around cancer screening and SDH resources as needed.

Active Comparator: Less Intensive (LI)

Participants randomized to LI arm will receive PN to social service needs + culturally and linguistically tailored cancer education materials. All individuals will complete a survey at baseline, 3 months, and 6 months. Once a participant randomized to the LI arm completes the 6-month survey, they will have the option to receive all navigational support provided by CHWs to individuals randomized to the PN arm.

Behavioral: Educational Materials
Both PN and LI participants will receive tailored educational materials around cancer screening and SDH resources as needed.

Behavioral: Patient Navigation (PN) - Less Intensive
The PN intervention will be administered by trained, bilingual CHWs: they will screen participants for social needs and provide navigational support to social services.

Outcome Measures

Primary Outcome Measures

  1. Percentage of Participants who Receive at Least 1 Cancer Screening at 6 Months After Study Enrollment [Up to Month 6]

    Cancer screening defined as a breast, cervical, or colorectal cancer screening.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women between the ages of 21 and 75 years;

  • Men between the ages of 50 and 75 years;

  • Women (50-74 years) who have not had a mammogram in the past 24 months, a Pap smear in the last 3 years (21-64 years old) or HPV test in the last 5 years (30-64 years old), or women 50-75 years old who are not up-to-date on colorectal cancer screening (Fecal occult blood test (FOBT)/Fecal immunochemical test (FIT) past year, computerized tomography (CT) colonography or sigmoidoscopy past 5 years, or colonoscopy past 10 years);

  • Men not up-to-date on colorectal cancer screening (FOBT/FIT past year, computerized tomography (CT) colonography or sigmoidoscopy past 5 years, or colonoscopy past 10 years);

  • Must speak either English, Spanish, Haitian-Creole, or Chinese Mandarin;

  • Lives in East Flatbush (zip codes: 11236, 11203, 11212); Sunset Park (zip codes: 11215, 11220, 11232); Highbridge (zip code 10452); or Morrisania (zip codes: 10456,

Exclusion Criteria:
  • Previous or current diagnosis of any cancer;

  • Pregnancy (breast and cervical cancer only);

  • Current participation in an existing cancer navigation program;

  • Currently in hospice care;

  • At least 66 years of age with advanced illness or frailty or who live in long-term institution for more than 90 days;

  • Bilateral mastectomy or right and left unilateral mastectomy (breast cancer only);

  • Hysterectomy with no residual cervix (cervical cancer only);

  • Total colectomy (colorectal cancer only).

Contacts and Locations

Locations

Site City State Country Postal Code
1 NYU Langone Health New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health
  • Centers for Disease Control and Prevention

Investigators

  • Principal Investigator: Chau Trinh, PhD, NYU Langone Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT05742178
Other Study ID Numbers:
  • 22-01516
First Posted:
Feb 23, 2023
Last Update Posted:
Feb 23, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Feb 23, 2023